Dongxu ZhaiFrankie H. F. LeeCheryl D’SouzaPing SuShouping ZhangZhengping JiaZhang LiAlbert H.C. WongFang Liu
The GluR2 -GAPDH complex represents a novel therapeutic target for the development of medications for MS that work through a different mechanism than existing treatments.
Wesley H. GodfreySoonmyung HwangKaho ChoShruthi ShanmukhaPayam GharibaniEfrat AbramsonMichael D. Kornberg
Lifei HouFlorian WinauEileen Remold‐O’Donnell
Rino InadaKatsuichi MiyamotoNoriko TanakaKota MoriguchiSusumu Kusunoki
Zhao‐Lan HuYanhui CuiXiaoqing QiaoXinwen HeFang LiCong LuoShuang WangChang-Qi LiRu-Ping Dai
Gopal MurugaiyanVanessa BeynonAkanksha MittalNicole JollerHoward L. Weiner